SYNLOGIC, INC. Share-based Payment Arrangement, Expense, Tax Benefit
SYNLOGIC, INC. (SYBX) reported Share-based Payment Arrangement, Expense, Tax Benefit of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2017-03-15
- SYNLOGIC, INC. share-based payment arrangement, expense, tax benefit for fiscal 2016 was $0.00.
- SYNLOGIC, INC. share-based payment arrangement, expense, tax benefit for fiscal 2015 was $0.00.
- SYNLOGIC, INC. share-based payment arrangement, expense, tax benefit for fiscal 2014 was $0.00.
- SYNLOGIC, INC. share-based payment arrangement, expense, tax benefit for fiscal 2013 was $0.00.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
| 2013-12-31 | $0.00 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |